Medical Device News Magazine

Musculoskeletal Organizations Support Bill to Mitigate Medicare Changes, Safeguard Care During COVID-19 Pandemic

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

November 16, 2020

Musculoskeletal organizations (63) are supporting a bill to mitigate Medicare changes and safeguard care during the COVID-19 pandemic. The support is for H.R. 8702, the Holding Providers Harmless from Medicare Cuts During COVID-19 Act of 2020.

In a November 16 letter to the bill’s sponsors, which include physician Representatives Ami Bera, Larry Bucshon, Roger Marshall, Phil Roe and Raul Ruiz, in addition to Representatives Brendan Boyle, George Holding and Abby Finkenauer, the group thanked them for introducing vital legislation that would mitigate Medicare cuts slated to go into effect in 2021 and allow for continued access to musculoskeletal services.

“Orthopaedic surgeons across the country play a critical role in safeguarding musculoskeletal health, treating bone cancers, chronic mobility problems, workplace injuries, and other pressing conditions,” wrote AAOS President Joseph A. Bosco III, MD, FAAOS. “It is essential that access to these services by the American public remain.”

Dr. Bosco continued by noting that practices are still struggling to treat backlogs of patients amid increasing demand for operating room time, rising COVID infection rates, and the continual need for access to musculoskeletal care for patients. He wrote, “Now is not the time to limit access to this essential care through destabilizing cuts to Medicare.”

The cuts being proposed by the Centers for Medicare & Medicaid Services (CMS) in the 2021 Medicare Physician Fee Schedule (MPFS) would reduce the value of all orthopaedic surgical services by 5% plus an additional 5% for hip and knee replacements. The legislation backed by orthopaedic groups would allow these regulatory changes to go into effect while offering a relief payment to mitigate the impact on surgeons in 2021 and 2022 as the COVID pandemic endures.

“Our organizations are proud to offer our support for H.R. 8702, the Holding Providers Harmless from Medicare Cuts During COVID-19 Act of 2020, and the two years of relief it will provide to Medicare orthopaedic professionals who are continuing to serve elderly and vulnerable populations across this country,” wrote Dr. Bosco. “We look forward to continuing to work with you as the champions of this vital legislation, to further congressional support and eventual passage of H.R. 8702 in upcoming congressional packages in 2020.”

In addition to leading this letter of support on behalf of the musculoskeletal community, the AAOS signed onto a similar November 11 letter from the larger medical community which can be found here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”